Clazakizumab
Clazakizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against interleukin-6.
| Trade Name | |
|---|---|
| Common Name | Clazakizumab |
| Indication | |
| Drug Class | Monoclonal antibodies: humanized, interleukins as target |
